Latest MiMedx Group Inc. Stories
MARIETTA, Ga., Feb. 1, 2011 /PRNewswire/ -- MiMedx Group, Inc. (OTC Bulletin Board: MDXG), an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today that they will be attending the American Academy of Orthopedic Surgeons (AAOS) Annual Meeting, February 15 - 19, 2011. The meeting will be held at the San Diego Convention Center in San Diego, California. MiMedx reported that it will have a sizable presence at AAOS this year to...
MARIETTA, Ga., Jan. 7, 2011 /PRNewswire/ -- MiMedx Group, Inc. (MDXG), an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today that it will present at the 13th Annual Needham Growth Conference in New York. Parker H. "Pete" Petit, Chairman and CEO, William C. Taylor, President and COO, and Michael J. Senken, CFO of MiMedx, are scheduled to present on Thursday, January 13th, at 9:40 a.m. Eastern Time at the New York Palace Hotel in...
MARIETTA, Ga., Jan. 5, 2011 /PRNewswire/ -- MiMedx Group, Inc. (OTC Bulletin Board: MDXG), an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today the completion of the purchase of Surgical Biologics, a leader in the development of tissue processing techniques for creating implants for a variety of surgical indications from amnion membranes. The deal was originally announced on December 21, 2010. This transaction expands MiMedx'...
MARIETTA, Ga., Dec. 23, 2010 /PRNewswire/ -- MiMedx Group, Inc. (OTC Bulletin Board: MDXG), an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today that it has received notification of the Class III certification for a European product using the Company's proprietary HydroFix(TM) technology. This certification for "post surgical adhesion inhibiting barriers" is in addition to the Company's previous certification for HydroFix(TM)...
MARIETTA, Ga., Dec. 21, 2010 /PRNewswire-FirstCall/ -- MiMedx Group, Inc. (OTC Bulletin Board: MDXG), an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today that it has signed a definitive agreement to acquire Surgical Biologics, a leader in the development of tissue processing techniques for creating implants for a variety of surgical indications from amnion membranes. Privately held Surgical Biologics was founded in early 2006...
MARIETTA, Ga., Dec. 1, 2010 /PRNewswire/ -- MiMedx Group, Inc. (OTC Bulletin Board: MDXG), an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today that it has been awarded a Qualifying Therapeutic Discovery Project grant (QTDP) from the U.S. Government. The grant, in the amount of $244,479, has been made to defer some of the Company's research expenditures related to the development of its novel and patented technology,...
MARIETTA, Ga., Oct. 26 /PRNewswire-FirstCall/ -- MiMedx Group, Inc. (OTC Bulletin Board: MDXG), an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today its results for the third quarter ended September 30, 2010. Results for Third Quarter Ended September 30, 2010 The Company recorded revenues during the quarter of approximately $108,000, as compared to $0 revenue for the same period in 2009 and $322,000 in the second quarter of...
MARIETTA, Ga., Oct. 5 /PRNewswire-FirstCall/ -- MiMedx Group, Inc. (OTC Bulletin Board: MDXG), an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today that its results for the third quarter, ended September 30, 2010, will be released before the opening of the market on Tuesday, October 26, 2010. MiMedx Group will host a live broadcast of its third quarter conference call on October 26, 2010, beginning at 10:30 a.m. Eastern Time. A...
MARIETTA, Ga., Sept. 29 /PRNewswire-FirstCall/ -- MiMedx Group, Inc. (OTC Bulletin Board: MDXG), an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today that it plans to proceed with an unregistered offering of shares through a Private Investment in Public Equity offering ("PIPE"). The proposed PIPE is intended to raise $5 million of equity capital and will be made to existing shareholders and other sophisticated qualified...
MARIETTA, Ga., July 23 /PRNewswire-FirstCall/ -- MiMedx Group, Inc. (OTC Bulletin Board: MDXG), an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today its results for the second quarter ended June 30, 2010. The Company recorded revenues during the quarter of $322,000, a significant increase over first quarter 2010 revenues of $115,000. The Company recorded a net loss of $2,700,000, or $0.04 per diluted common share, for the...
